In clinical trials, Semaglutide resulted in an average weight loss of 15% over 68 weeks, while Tirzepatide achieved up to 20% over 72 weeks, both paired with diet and exercise
Davies M, Faerch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al
This hormone tells the brain we are full and no longer need to eat
A personalised approach - assessing nutrient status, microbiome balance, and medication interactions - can accelerate recovery and help procedures succeed
This is especially relevant for individuals on multiple blood pressure medications or diuretics
Diabetes Res Clin Pract 103:137149 Kraschnewski JL, Boan J, Esposito J et al (2010) Long-term weight loss maintenance in the United States